Table 3.
Prior-statin according to age, sex, socio-economic status and ASCVD stratification
| Statin treatment | High intensity | Moderate intensity | Low intensity | |||||
|---|---|---|---|---|---|---|---|---|
| VHR | Non-VHR | VHR | Non-VHR | VHR | Non-VHR | VHR | Non-VHR | |
| Total | 78% (1979) | 70% (5199) | 3% (80) | 2% (143) | 71% (1800) | 64% (4708) | 4% (99) | 5% (348) |
| N | 2542 | 7402 | ||||||
| Sex group | ||||||||
| Male | 79% (1698) | 72% (3666) | 3% (64) | 2% (103) | 72% (1547) | 65% (3336) | 4% (87) | 4% (227) |
| N | 2157 | 5111 | ||||||
| Female | 73% (281) | 67% (1533) | 4% (16) | 2% (40) | 66% (253) | 60% (1372) | 3% (12) | 5% (121) |
| N | 385 | 2291 | ||||||
| Age group | ||||||||
| <45 years | 77% (399) | 70% (428) | 5% (28) | 2% (12) | 68% (352) | 62% (381) | 4% (19) | 6% (35) |
| N | 518 | 612 | ||||||
| 45-54 years | 82% (430) | 71% (1356) | 4% (19) | 2% (46) | 74% (389) | 64% (1236) | 4% (22) | 4% (74) |
| N | 525 | 1917 | ||||||
| 55-64 years | 79% (633) | 71% (2105) | 2% (20) | 2% (57) | 73% (584) | 64% (1894) | 4% (29) | 5% (154) |
| N | 802 | 2976 | ||||||
| ≥65 years | 74% (517) | 69% (1310) | 2% (13) | 1% (28) | 68% (475) | 63% (1197) | 4% (29) | 4% (85) |
| N | 697 | 1897 | ||||||
| Socio-economic group | ||||||||
| High income | 78% (641) | 71% (1802) | 4% (29) | 2% (55) | 70% (578) | 64% (1635) | 4% (34) | 4% (112) |
| N | 826 | 2554 | ||||||
| Middle income | 79% (966) | 71% (2485) | 3% (35) | 2% (70) | 72% (881) | 64% (2250) | 4% (50) | 5% (165) |
| N | 1218 | 3508 | ||||||
| Low income | 75% (372) | 68% (912) | 3% (16) | 1% (18) | 68% (341) | 61% (823) | 3% (15) | 5% (71) |
| N | 498 | 1340 | ||||||
Data shown are %(n). Number of patients with VHR or non-VHR in respective group of each line shown are N. ASCVD, atherosclerotic cardiovascular disease; VHR, very-high-risk.